Delivery Order SPE2DB24D2012-SPE2DB25FBWKX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,027.44 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,777.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 12 mg tablets (30-count units), with a completion deadline of June 2, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) with a ceiling value of $1,027.44. This firm fixed-price delivery order, awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.80 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 10, 2025 and is not designated with a set-aside. The contract provides for the delivery of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,231.73 contract is for the delivery of FYCOMPA 6 MG tablets to support military healthcare programs. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWKXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.38 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 15, 2025, with an ultimate completion date of July 16, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply chain requirements across multiple therapeutic domains, positioning the company as a critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/15/25 |